AzurRx BioPharma Inc (AZRX)


Stock Price Forecast

Oct. 21, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AzurRx BioPharma Inc chart...

About the Company

We do not have any company description for AzurRx BioPharma Inc at the moment.

Exchange

NASDAQ

$214M

Total Revenue

12

Employees

$15M

Market Capitalization

-0.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AZRX News

Future Arca BioPharma ops ‘highly dependent’ on Oruka merger

1h ago, source: BizWest

The future of  Arca Biopharma is “highly dependent” on the successful consummation of its merger with Oruka Therapeutics Inc.

First Wave BioPharma Inc (FWBI)

17d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

GT Biopharma Inc GTBP

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Q4 2023 Cue Biopharma Inc Earnings Call

17d ago, source: Yahoo Finance

Stephen Willey; Analyst; Stifel Financial Corp. Reni Benjamin; Analyst; JMP Securities LLC Operator Greetings, and welcome to the Cue Biopharma Investor Update Call. (Operator Instructions ...

ArriVent BioPharma, Inc. (AVBP)

4d ago, source: Yahoo Finance

NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical ...

ABVC BioPharma Inc

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aytu BioPharma Inc.

11d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cue Biopharma Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SBFM Sunshine Biopharma, Inc.

10d ago, source: Seeking Alpha

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is ...

Aytu BioPharma, Inc. Common Stock (AYTU)

2mon ago, source: Nasdaq

Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ...

First Wave BioPharma Inc (FWBI)

1mon ago, source: Investing

First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic ...

First Wave BioPharma Inc (FWBI)

11d ago, source: Investing

In a recent move, James Sapirstein, the Chairman and CEO of First Wave BioPharma, Inc. (NASDAQ:FWBI), sold a total of 1,887 shares of the company's common stock. The transaction, ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...